ELDN
Eledon Pharmaceuticals Inc
NASDAQ: ELDN · HEALTHCARE · BIOTECHNOLOGY
$3.64
+8.98% today
Updated 2026-04-30
Market cap
$275.92M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.52
Dividend yield
—
52W range
$1 – $5
Volume
1.5M
Eledon Pharmaceuticals Inc (ELDN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.33M | $-15.48M | $-21.12M | $-41.24M | $-36.52M | $-14.94M | $-11.89M | $-13.86M | $-15.21M | $-28.91M | $-28.42M | $-39.53M | $-47.27M | $-62.34M |
| Capital expenditures | $8000.00 | $23000.00 | $25000.00 | $565000.00 | $17000.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Stock-based comp | $210000.00 | $238000.00 | $2.11M | $2.90M | $3.00M | $579000.00 | $1.54M | $1.31M | $3.17M | $7.90M | $8.15M | $6.54M | $13.12M | $10.45M |
| Free cash flow | $-9.34M | $-15.50M | $-21.15M | $-41.80M | $-36.54M | $-14.94M | $-11.89M | $-13.86M | $-15.21M | $-28.91M | $-28.42M | $-39.53M | $-47.27M | $-62.34M |
| Investing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — | $25000.00 | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — |